Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on September 24, 2025
Sparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes
PORTLAND, Ore., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced the close of a $95 million Series B financing. The round was co-led by RA Capital Management and Forbion with …
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
SAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- Sapu Nano, developer of Deciparticle™, today announced that it has received approval from Australia’s Human Research Ethics Committee (HREC) to begin enrolling patients in a Phase 1 human clinical …
Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
ATHENS, Greece and SOLANA BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in EMEA region, today announced that it has signed an agreement with …
California Resources Corporation Announces Private Offering of $400 Million of Senior Unsecured Notes
LONG BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (the “Company”) announced today that, subject to market and other conditions, it intends to offer and sell to eligible purchasers $400 million in aggregate …
BPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025
BOSTON, Sept. 24, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced its sponsorship of the MitoAction Energy Walk at Boston’s Franklin Park …
XT.COM Unveils Brand Overhaul: Xplore Crypto, Trade with Trust
VICTORIA, Seychelles, Sept. 24, 2025 (GLOBE NEWSWIRE) -- As global demand for faster, safer, and more intuitive digital asset trading continues to rise, XT.COM has taken a decisive step forward with the launch of its most ambitious user interface overhaul …
Global Energy Partner Backs Max Power With $5 Million to Target Natural Hydrogen Discovery in Saskatchewan
VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) has arranged a non-brokered private placement (the “Offering”) of common shares with a leading …
Nevada Lithium Resources and Hydro Lithium sign Letter of Intent for Development of Bonnie Claire Critical Minerals
VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nevada Lithium Resources Inc. (TSXV: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company”) is pleased to announce that on September 7, 2025, it signed a non-binding Letter of …
Apollo Silver Engages Capital Analytica for Marketing and Social Media Services
VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo Silver” or the “Company”) (TSX.V:APGO; OTCQB:APGOF; Frankfurt:6ZF0) is pleased to announce that it has engaged Triomphe Holdings Ltd., doing business as Capital …
Oroco Welcomes Faysal Rodriguez to its Board of Directors
VANCOUVER, Canada, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTCQB: ORRCF) (“Oroco” or “the Company”) is pleased to announce the appointment of Mr. Faysal Rodriguez to its Board of Directors. Mr. Rodriguez is a seasoned mining …
Lancaster Resources Rock Assay Results from Lake Cargelligo Gold Project
VANCOUVER, British Columbia, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF) (“Lancaster”), is pleased to announce rock assaying results from their mineral claims at the 100% owned Lake Cargelligo Gold …
American Tungsten Advances Rehabilitation Efforts at IMA And Enters into LOI for U.S-based Offtake
Vancouver, BC, Sept. 24, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:TUNGF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to report continued progress on the Zero Level rehabilitation project at the IMA Mine, with …
MEXC Foundation Fuels Local Impact in First Philippine Community Initiative 'Golf for a Cause'
VICTORIA, Seychelles, Sept. 24, 2025 (GLOBE NEWSWIRE) -- MEXC Foundation, the impact-driven arm of leading global crypto exchange MEXC, has marked its inaugural community fundraising initiative by serving as Platinum Sponsor of "Golf for a Cause," the 2nd …
MEXC Launches "Race to Zero" Event with a Total Prize Pool of Up to 2 BTC
VICTORIA, Seychelles, Sept. 24, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has launched its latest "Race to Zero" event with a total prize pool of up to 2 BTC. The event combines innovative gameplay with substantial rewards, …
First Atlantic Nickel Renames Atlantic Nickel Project to Pipestone XL to Reflect 100% Ownership of 30 km Pipestone Ophiolite Complex and Provides Updates on RPM Phase 2x Program
GRAND FALLS-WINDSOR, Newfoundland and Labrador, Sept. 24, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce that it has renamed its flagship Atlantic Nickel …
ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161
Garching / Munich, Germany, and Breda, the Netherlands, September 24, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and TerThera BV, a leading provider of GMP-grade Terbium-161, today announced a supply …
Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health
The studies established the lead asset to be well tolerated in healthy volunteers at all doses with a good safety profile SYT-510 demonstrated penetration in the central nervous system and a pharmacodynamic effect on the brain BASEL, Switzerland, Sept. 24, …